MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (โAvenueโ or the...
PDUFA goal date of November 4, 2024 for DFD-29 for the treatment of inflammatory lesions and erythema of...
- Last patient visit complete in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy;...
MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (โAvenueโ or the...
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (โAvenueโ or the โCompanyโ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.